Page 113 - CL Armchair Case
P. 113
At the time Shkreli claimed he wanted to buy SeraCare, his
hedge fund was actually suffering steep losses.
In New York, in mid December, 2015 Shkreli said if he could
have done it over (Daraprim),
“I probably would have raised the price higher,” adding,
“My investors expect me to maximize profits.”
However, Shkreli like a few other health-care firms - ones
that acquire the rights to drugs and significantly increase
their prices - was drawing the scrutiny of regulators and
prosecutors, with a possible daunting effect on aggressive
drug-pricing strategies.
“Can I play Pokémon Go now?”
In January Shkreli retained criminal defense attorney
Benjamin Brafman to defend him.
He was subpoenaed to appear before the Committee on
Oversight and Government Reform of the U.S. House of
Representatives to answer questions about the Daraprim
price increase.
On February 4, 2016, Shkreli appeared before the House
committee.
